<ѻýҕl>Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinismѻýҕl> Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024
<ѻýҕl>T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans?ѻýҕl> News and commentary from the endocrinology world Jan 23, 2024
<ѻýҕl>Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Painѻýҕl> News and commentary from the endocrinology world Jan 16, 2024
<ѻýҕl>FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Nowѻýҕl> Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
<ѻýҕl>T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Winѻýҕl> News and commentary from the endocrinology world Jan 09, 2024
<ѻýҕl>No Increased Risk of Suicidal Ideation With GLP-1 Drugsѻýҕl> Semaglutide shows lower risk of suicidal ideation than other obesity, diabetes drugs Jan 08, 2024
<ѻýҕl>Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Riskѻýҕl> But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
<ѻýҕl>Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonistsѻýҕl> Researchers looked at 7-year patient data Jan 04, 2024
<ѻýҕl>In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protectiveѻýҕl> Risk of all-cause mortality, MAKE, and MACE were significantly reduced Jan 04, 2024
<ѻýҕl>Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woesѻýҕl> News and commentary from the endocrinology world Jan 02, 2024
<ѻýҕl>Bernie Sanders Has COVID; Global Fake Ozempic Problem; Nitazenes, the New Fentanyl?ѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Dec 29, 2023
<ѻýҕl>Food as Diabetes Medicine? Maybe Not, Trial Suggestsѻýҕl> But intensive program did help boost engagement with healthcare Dec 26, 2023
<ѻýҕl>Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealthѻýҕl> News and commentary from the endocrinology world Dec 26, 2023
<ѻýҕl>Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Recordsѻýҕl> "What is the threshold for the FDA to step in and do something?" Dec 24, 2023
<ѻýҕl>Beware of Fake Ozempic, FDA Warnsѻýҕl> Agency seized thousands of counterfeit units already Dec 22, 2023
<ѻýҕl>Can a GLP-1 Agonist Improve Parkinson's Symptoms?ѻýҕl> A version of exenatide failed a phase II trial, but hinted at benefits in patients under 60 Dec 19, 2023
<ѻýҕl>Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industryѻýҕl> News and commentary from the endocrinology world Dec 19, 2023
<ѻýҕl>Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gainѻýҕl> Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
<ѻýҕl>Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadaversѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Dec 14, 2023
<ѻýҕl>Stopping Tirzepatide Led to Weight Gain, Trial Showsѻýҕl> But sustained treatment kept the pounds off Dec 13, 2023
<ѻýҕl>New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelvesѻýҕl> News and commentary from the endocrinology world Dec 12, 2023
<ѻýҕl>Metformin for Diabetes in Pregnancy: Maybe Not, Trial Saysѻýҕl> New trial complicates findings of previous studies Dec 12, 2023
<ѻýҕl>GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patientsѻýҕl> Association strongest in patients with overweight, obesity Dec 07, 2023
<ѻýҕl>Quick Albuminuria Reduction Key Factor in Finerenone's Efficacyѻýҕl> 4-month UACR reduction mediated 84% of kidney treatment effect Dec 05, 2023
<ѻýҕl>Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonistsѻýҕl> Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
<ѻýҕl>Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVDѻýҕl> Intervention persuaded VA physicians to adjust care, helped lower HbA1c Dec 04, 2023
<ѻýҕl>Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2Dѻýҕl> News and commentary from the endocrinology world Dec 04, 2023
<ѻýҕl>Orphan Drug Costs; Digital Devices for Diabetesѻýҕl> Also in TTHealthWatch: smoking cessation benefits Dec 02, 2023 podcast
<ѻýҕl>'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trialѻýҕl> Voice-based app helped users to titrate basal insulin at home Dec 01, 2023
<ѻýҕl>Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosisѻýҕl> News and commentary from the endocrinology world Nov 27, 2023
<ѻýҕl>Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'dѻýҕl> News and commentary from the endocrinology world Nov 21, 2023
<ѻýҕl>Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Eventsѻýҕl> Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
<ѻýҕl>Brolucizumab Noninferior to Aflibercept for Diabetic Macular Edemaѻýҕl> At a non-approved dose, the anti-VEGF drug had similar outcomes as rival Nov 17, 2023
<ѻýҕl>Even Small Diabetes Distress Changes Clinically Importantѻýҕl> Researchers calculated cutoffs for significant DDS-17 scale changes Nov 15, 2023
<ѻýҕl>One Copeptin Test More Accurate as Diagnostic for AVP Deficiencyѻýҕl> However, this test was more complicated, with more side effects, researchers note Nov 15, 2023
<ѻýҕl>Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woesѻýҕl> News and commentary from the endocrinology world Nov 14, 2023
<ѻýҕl>Diabetes Linked to Higher Colorectal Cancer Riskѻýҕl> Associated risks highest in those with recent diagnoses Nov 14, 2023
<ѻýҕl>Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Diseaseѻýҕl> Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
<ѻýҕl>AMA Supports Tighter Restrictions to Curb Pollution From Industrialized Farmsѻýҕl> Concentrated Animal Feeding Operations "may be a public health hazard," group says Nov 14, 2023
<ѻýҕl>Tirzepatide Wins FDA Approval for Weight Lossѻýҕl> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023